211 related articles for article (PubMed ID: 25752415)
1. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia.
Pérez-López J; Selva-O'Callaghan A; Grau-Junyent JM; Gallego-Galindo L; Coll MJ; García-Morillo S; Torralba-Cabeza MA; Vilardell-Tarrés M
Mol Genet Metab; 2015 Apr; 114(4):580-3. PubMed ID: 25752415
[TBL] [Abstract][Full Text] [Related]
2. Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort.
Gutiérrez-Rivas E; Bautista J; Vílchez JJ; Muelas N; Díaz-Manera J; Illa I; Martínez-Arroyo A; Olivé M; Sanz I; Arpa J; Fernández-Torrón R; López de Munáin A; Jiménez L; Solera J; Lukacs Z
Neuromuscul Disord; 2015 Jul; 25(7):548-53. PubMed ID: 25998610
[TBL] [Abstract][Full Text] [Related]
3. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
[TBL] [Abstract][Full Text] [Related]
4. The frequency of late-onset Pompe disease in pediatric patients with limb-girdle muscle weakness and nonspecific hyperCKemia: A multicenter study.
Ünver O; Hacıfazlıoğlu NE; Karatoprak E; Güneş AS; Sağer G; Kutlubay B; Sözen G; Saltık S; Yılmaz K; Kara B; Türkdoğan D
Neuromuscul Disord; 2016 Nov; 26(11):796-800. PubMed ID: 27666774
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.
Lukacs Z; Nieves Cobos P; Wenninger S; Willis TA; Guglieri M; Roberts M; Quinlivan R; Hilton-Jones D; Evangelista T; Zierz S; Schlotter-Weigel B; Walter MC; Reilich P; Klopstock T; Deschauer M; Straub V; Müller-Felber W; Schoser B
Neurology; 2016 Jul; 87(3):295-8. PubMed ID: 27170567
[TBL] [Abstract][Full Text] [Related]
6. Screening for late-onset Pompe disease in Finland.
Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B
Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669
[TBL] [Abstract][Full Text] [Related]
7. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S
J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
Lorenzoni PJ; Kay CSK; Higashi NS; D'Almeida V; Werneck LC; Scola RH
Arq Neuropsiquiatr; 2018 Apr; 76(4):247-251. PubMed ID: 29742245
[TBL] [Abstract][Full Text] [Related]
9. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
[TBL] [Abstract][Full Text] [Related]
10. Screening for late-onset Pompe disease in Internal Medicine departments in Spain.
López-Rodríguez M; Torralba-Cabeza MA; de Pedro IP; Rivera A; Gil RS; Gómez-Belda A; de la Peña JLP; de Los Santos Moreno A; Selva-O'Callaghan A; Gárate IG; García AG; Hurtado R; de Ureta PT; Barba-Romero MÁ; Milisenda JC; Grau-Junyent JM;
Orphanet J Rare Dis; 2023 Aug; 18(1):256. PubMed ID: 37653444
[TBL] [Abstract][Full Text] [Related]
11. Should patients with asymptomatic pompe disease be treated? A nationwide study in France.
Echaniz-Laguna A; Carlier RY; Laloui K; Carlier P; Salort-Campana E; Pouget J; Laforet P
Muscle Nerve; 2015 Jun; 51(6):884-9. PubMed ID: 25786784
[TBL] [Abstract][Full Text] [Related]
12. Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study.
Reynolds TM; Tylee K; Booth K; Wierzbicki AS; ;
J Clin Pathol; 2019 Dec; 72(12):805-809. PubMed ID: 31308256
[TBL] [Abstract][Full Text] [Related]
13. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.
Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J
Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease.
Savarese M; Torella A; Musumeci O; Angelini C; Astrea G; Bello L; Bruno C; Comi GP; Di Fruscio G; Piluso G; Di Iorio G; Ergoli M; Esposito G; Fanin M; Farina O; Fiorillo C; Garofalo A; Giugliano T; Magri F; Minetti C; Moggio M; Passamano L; Pegoraro E; Picillo E; Sampaolo S; Santorelli FM; Semplicini C; Udd B; Toscano A; Politano L; Nigro V
Neuromuscul Disord; 2018 Jul; 28(7):586-591. PubMed ID: 29880332
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for Pompe disease in Japan.
Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic criteria for late-onset (childhood and adult) Pompe disease.
American Association of Neuromuscular & Electrodiagnostic Medicine
Muscle Nerve; 2009 Jul; 40(1):149-60. PubMed ID: 19533647
[TBL] [Abstract][Full Text] [Related]
17. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory.
Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS
Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645
[TBL] [Abstract][Full Text] [Related]
18. Screening for late-onset Pompe disease in Poland.
Jastrzębska A; Potulska-Chromik A; Łusakowska A; Jastrzębski M; Lipowska M; Kierdaszuk B; Kamińska A; Kostera-Pruszczyk A
Acta Neurol Scand; 2019 Oct; 140(4):239-243. PubMed ID: 31125121
[TBL] [Abstract][Full Text] [Related]
19. Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion.
Marotto D; Moschetti M; Lo Curto A; Spezzigu AM; Giacomarra M; Marsana EM; Zizzo C; Duro G; Colomba P
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958907
[TBL] [Abstract][Full Text] [Related]
20. Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry.
Kishnani PS; Amartino HM; Lindberg C; Miller TM; Wilson A; Keutzer J
Mol Genet Metab; 2014; 113(1-2):84-91. PubMed ID: 25085280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
